Two-Year Primary Patency Rates After Aortoiliac Occlusive Disease Endovascular Treatment

Two-Year Primary Patency Rates After Aortoiliac Occlusive Disease Endovascular Treatment Publisher

Hassani M¹ ; Zafarghandi MR² ; Taghavi M² ; Salimi J² ; Moini M² ; Sharifi A² ; Noaparast M² ; Toubaei MR² ; Shahbandari M³ ; Naserinia SA⁴ ; Saadat S² ; Biniaz F⁵

Show Affiliations

1. Department of Surgery, Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2. Sina Trauma and Surgery Research Center, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran
3. Isfahan University of Medical Sciences, Isfahan, Iran
4. Ethics Group of Tehran University of Medical Sciences, Tehran, Iran
5. Department of Radiology, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran

Source: Iranian Journal of Radiology Published:2018

Abstract

Background: In the last decade, great attention has been paid to endovascular treatment and now it is considered as a treatment of choice in aortoiliac occlusive disease. Objectives: To report our 2-year follow-up experience in this field. Patients and Methods: A retrospective review was conducted on patients who underwent aortoiliac angioplasty with or without stenting from September 2013 to March 2015. Medical profile, clinical signs and symptoms, and technical variables of angioplasty were recorded. Technical success rate and primary patency rate were the main outcome measures. Results: Fifty eight patients (m:f = 53:5) with the mean age of 64.28 ± 10.88 years and the most common initial presentation of intermittent claudication (37.9%) were evaluated. The technical success rate was 100% in each transatlantic inter-society consensus (TASC) subtypes. The mean time of hospital stay was 9.45 ± 7.96 days. The mean follow up period was 14.01 ± 5.87 months (6-27months). The Kaplan-Meier analysis estimated a primary patency rate of TASC subtypes A-D at 1 year as 96.3%, 100%, 66.7%, and 96.3%, respectively. Two years primary patency rates were 96.3%, 100%, 66.7%, and 81.6% for A-D TASC subtypes, respectively. There was no complication or death in the study group. Conclusion: Endovascular treatment for different TASC II subtypes is associated with considerable technical success rate and primary patency rate even in TASC D, which has been previously indicated to be treated with open surgical procedures. © 2018, Iranian Journal of Radiology.

Related Docs

View other Related Docs

1. Clinical Outcomes of Reconstructive Surgery of Aortic Coarctation in Patients Hospitalized in Shahid Chamran Hospital, Isfahan, Iran, During 2011-2015, Journal of Isfahan Medical School (2017)

2. Our First Experience in Stenting of Coarctation of Aorta in Infants and Small Children; a Case Series Study, ARYA Atherosclerosis (2019)

3. Stent Underexpansion in Angiographic Guided Percutaneous Coronary Intervention, Despite Adjunctive Balloon Post-Dilatation, in Drug Eluting Stent Era, ARYA Atherosclerosis (2014)

4. Venoplasty and Venous Stenting in Patients With Chronic Venous Insufficiency in the Lower Extremities, Journal of Tehran University Heart Center (2016)

5. Short and One-Year Outcome of Endovascular Aortic Repair (Evar) for Abdominal Aortic Aneurysms (Aaas), ARYA Atherosclerosis (2022)

6. The Impact of Generic Form of Clopidogrel on Cardiovascular Events in Patients With Coronary Artery Stent: Results of the Opces Study, Journal of Research in Medical Sciences (2011)

7. Blood Group Types and Clinical, Procedural, and Adverse Outcomes in St-Elevated Myocardial Infarction Patients: A 3-Year Cohort in Iran, Journal of Research in Medical Sciences (2023)

8. Evaluation of Coronary Angioplasty Results in Patients Referring to Isfahan Cardiac Centers, Iran, and Comparing With Clinical Guidelines, Journal of Isfahan Medical School (2017)

Experts (# of related papers)

View all Related Experts

Alireza Khosravi (3)

Nizal Sarrafzadegan (2)

Style	Citing Format
MLA	Hassani M, et al.. "Two-Year Primary Patency Rates After Aortoiliac Occlusive Disease Endovascular Treatment." Iranian Journal of Radiology, vol. 15, no. 2, 2018, pp. -.
APA	Hassani M, Zafarghandi MR, Taghavi M, Salimi J, Moini M, Sharifi A, Noaparast M, Toubaei MR, Shahbandari M, Naserinia SA, Saadat S, Biniaz F (2018). Two-Year Primary Patency Rates After Aortoiliac Occlusive Disease Endovascular Treatment. Iranian Journal of Radiology, 15(2), -.
Chicago	Hassani M, Zafarghandi MR, Taghavi M, Salimi J, Moini M, Sharifi A, Noaparast M, et al.. "Two-Year Primary Patency Rates After Aortoiliac Occlusive Disease Endovascular Treatment." Iranian Journal of Radiology 15, no. 2 (2018): -.
Harvard	Hassani M et al. (2018) 'Two-Year Primary Patency Rates After Aortoiliac Occlusive Disease Endovascular Treatment', Iranian Journal of Radiology, 15(2), pp. -.
Vancouver	Hassani M, Zafarghandi MR, Taghavi M, Salimi J, Moini M, Sharifi A, et al.. Two-Year Primary Patency Rates After Aortoiliac Occlusive Disease Endovascular Treatment. Iranian Journal of Radiology. 2018;15(2):-.
BibTex	@article{ author = {Hassani M and Zafarghandi MR and Taghavi M and Salimi J and Moini M and Sharifi A and Noaparast M and Toubaei MR and Shahbandari M and Naserinia SA and Saadat S and Biniaz F}, title = {Two-Year Primary Patency Rates After Aortoiliac Occlusive Disease Endovascular Treatment}, journal = {Iranian Journal of Radiology}, volume = {15}, number = {2}, pages = {-}, year = {2018} }
RIS	TY - JOUR AU - Hassani M AU - Zafarghandi MR AU - Taghavi M AU - Salimi J AU - Moini M AU - Sharifi A AU - Noaparast M AU - Toubaei MR AU - Shahbandari M AU - Naserinia SA AU - Saadat S AU - Biniaz F TI - Two-Year Primary Patency Rates After Aortoiliac Occlusive Disease Endovascular Treatment JO - Iranian Journal of Radiology VL - 15 IS - 2 SP - EP - PY - 2018 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract